MRI study comparing blood thinners after a certain stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial looks at MRI scans to compare two types of blood-thinning medicines (one that affects blood-clotting and one that affects platelets) after a recent stroke caused by severe narrowing in certain brain arteries. It may help doctors understand which treatment works best while checking how the blood vessels and brain tissue look on MRI.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must already be enrolled in the CAPTIVA stroke trial
- Your stroke must have happened within the last 30 days and not have caused lasting severe disability
- Your stroke needs to be linked to 70–99% narrowing in specific brain arteries (ICA, MCA, BA, or VA)
- You must be able to get a baseline MRI within 14 days of starting CAPTIVA
- You must be able and willing to have MRI scans (no MRI safety problems like certain pacemakers)
- You must not have a gadolinium contrast allergy and must not have very poor kidney function (eGFR under 30)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses special brain MRI to look closely at plaque in certain brain arteries after an ischemic stroke (when a blood vessel is blocked). It may help researchers better understand which plaques are most dangerous soon after stroke.
This study investigates the build-up of fatty deposits called plaques in arteries of the brain and neck using two different strengths of MRI scanners. It aims to understand how well these MRI techniques can image the plaques, which could help doctors better diagnose and manage stroke risk.
This study looks at inflammation signals in the body and in brain MRI scans after treatment to reopen a blocked brain artery. It may help researchers understand who benefits most from different “reperfusion” treatments like clot-busting medicine or procedures.
This trial is testing an interventional treatment for people who have severe narrowing (70-99%) in a major brain artery that has caused a stroke or mini-stroke in the past year. The goal is to see if this treatment can help prevent future strokes.
This study uses a special type of MRI called vessel wall MRI to tell the difference between two causes of stroke: hardening of the arteries (atherosclerosis) and inflammation of the blood vessels (vasculitis). It may help doctors decide the best treatment for your stroke.
This trial tests a combination of two blood thinners (antiplatelet drugs) to see if they work better than one in people who had a mild stroke caused by a narrowed artery in the brain. If you had a recent first stroke and are otherwise healthy, you may be able to join.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.